Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression

Journal of Neuroscience Research

Volumn 83, Issue 8, 2006, Pages 1432-1446

  Venken, Koen ^a   Hellings, Niels ^a   Hensen, Karen ^b   Rummens, Jean Luc ^b   Medaer, Robert ^a   D'Hooghe, Marie B ^c   Dubois, Bénédicte ^d   Raus, Jef ^a   Stinissen, Piet ^a,e  

^a HASSELT UNIVERSITY   (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

^c National MS Centre   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e HASSELT UNIVERSITY   (Belgium)

Author keywords

CD4+CD25+ regulatory T cells; FOXP3; Multiple sclerosis

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; REMISSION;

EID: 33744904725     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20852     Document Type: Article

References (41)

1. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995-1004.
2. high regulatory cells in human peripheral blood. J Immunol 167:1245-1253.
3. + T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105:735-741.
4. + T cells via a CD30-dependent mechanism. J Clin Invest 113:310-317.
5. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435-6443.
6. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277-285.
7. + regulatory T cells. Nat Immunol 4:330-336.
8. + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A 100:10878-10883.
9. high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35:3343-3352.
10. Hellings N, Baree M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P. 2001. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J Neurosci Res 63:290-302.
11. Hellings N, Raus J, Stinissen P. 2002. Insights into the immunopathogenesis of multiple sclerosis. Immunol Res 25:27-51.
12. + regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A 102:6449-6454.
13. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061.
14. Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA. 2005. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81:45-52.
15. Hug A, Korporal M, Schroder I, Haas J, Glatz K, Storch-Hagenlocher B, Wildemann B. 2003. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol 171:432-437.
16. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285-1294.
17. + T regulatory cells. Nat Immunol 4:337-342.
18. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169:4712-4716.
19. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199:1285-1291.
20. + regulatory cells within the central nervous system. J Immunol 175:3025-3032.
21. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629-644.
22. Noseworthy JH. 2003. Neurological therapeutics: principals and practice. London: Martin Dunitz.1108 p.
23. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 196:237-246.
24. high T regulatory cells and their IL-10 production in multiple sclerosis. J Neuroimmunol 144:125-131.
25. + regulatory cells that control intestinal inflammation. J Exp Med 192:295-302.
26. + regulatory T cells at the single-cell level. Eur J Immunol 35:1681-1691.
27. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562.
28. Shevach EM. 2000. Regulatory T cells in autoimmmunity. Annu Rev Immunol 18:423-449.
29. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3:135-142.
30. Sorensen TL, Sellebjerg F. 2001. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Neurology 57: 1371-1376.
31. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31:1247-1254.
32. + T cell responses. J Exp Med 198:889-901.
33. + T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31:1122-1131.
34. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192:303-310.
35. Thewissen M, Linsen L, Somers V, Geusens P, Raus J, Stinissen P. 2005. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Ann N Y Acad Sci 1051:255-262.
36. + Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 74:296-308.
37. van Parijs L, Abbas AK. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243-248.
38. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971-979.
39. Wei WZ, Morris GP, Kong YC. 2004. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53:73-78.
40. Zamvil SS, Steinman L. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579-621.
41. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179:973-984.